Hugo González

548 citations
6 papers · 98 indexed · h-index 5
Topics
Chronic Lymphocytic Leukemia Research (3 papers)Lymphoma Diagnosis and Treatment (2 papers)Immunodeficiency and Autoimmune Disorders (2 papers)
Partner nations
France

In The Last Decade

Hugo González

6 papers receiving 94 citations

Peers

Hugo González
Comparison fields: 5 of 43
  • Genetics 38
  • Pathology and Forensic Medicine 28
  • Molecular Biology 25
  • Immunology 18
  • Physiology 17
Replace Si̇nan Demi̇rci̇oğlu with:
Si̇nan Demi̇rci̇oğlu Türkiye
Stephen B. Fritz United States
Aasiya Matin United States
M Gergely United States
Sunita Goyal India
Zahidul Alam Bangladesh
Hussein H. Karnib Lebanon
Lucia Fontana Italy
M. Micheau France
I Diéguez Spain
Hugo González relative to Si̇nan Demi̇rci̇oğlu Türkiye Si̇nan Demi̇rci̇oğlu's profile →
Citations per field
00.5×
Si̇nan Demi̇rci̇oğlu · 1×
Citations per year

Countries citing papers authored by Hugo González

Since Specialization
Citations

This map shows the geographic impact of Hugo González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo González more than expected).

Fields of papers citing papers by Hugo González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo González. The network helps show where Hugo González may publish in the future.

Co-authorship network of co-authors of Hugo González

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo González. A scholar is included among the top collaborators of Hugo González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo González. Hugo González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 22
2 4
3 3
4 5
5
Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
29
6 35

About Hugo González

Hugo González is a scholar working on Toxicology, Genetics and Gastroenterology, having authored 6 papers that have together received 98 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Genetics (38 citations), Gastroenterology (12 citations) and Pathology and Forensic Medicine (28 citations). Hugo González has collaborated with scholars based in France. Frequent co-authors include Juan A. De Paula, Juan Carlos Pernas, S. Pons, Jean Gabarre, Nabih Azar, J L Binet, G Dighiero, J P Vernant, Laurent Sutton and Valérie Leblond. Their work appears in journals such as Clinical Pharmacokinetics, Digestive Diseases and Sciences and Leukemia & lymphoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026